Transactions by persons discharging managerial responsibilities and persons closely associated with them Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group") 12 July 2019 NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM On 11 July 2019, Dr Ronnie Van der Merwe purchased 11 000 shares in Mediclinic International plc at ZAR 56.90 per share. Accordingly, Dr Van der Merwe now owns a total of 51 630 Shares. The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation. 1. Details of PDMR / persons closely associated with them ("PCA") a) Name Dr Carel Aron van der Merwe 2. Reason for the notification a) Position / status Chief Executive Officer - Mediclinic International plc b) Initial notification / Initial Notification amendment 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Mediclinic International plc b) LEI 2138002S5BSBIZTD5I60 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the Ordinary Shares financial instrument Identification Code GB00B8HX8Z88 b) Nature of the Purchase of shares transaction c) Price(s) and Price(s) Volume(s) volume(s) ZAR 56.84 per share 1 000 ZAR 56.85 per share 2 831 ZAR 56.86 per share 1 000 ZAR 56.87 per share 3 000 ZAR 56.98 per share 2 000 ZAR 57.00 per share 1 169 d) Aggregated information Aggregated volume 11 000 Price ZAR 56.90 e) Date of the 11 July 2019 transaction f) Place of the Johannesburg Stock Exchange transaction About Mediclinic International plc Mediclinic is an international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. The Group's core purpose is to enhance the quality of life. Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets. Mediclinic comprises 77 hospitals, five sub-acute hospitals, 12 day case clinics and 21 outpatient clinics. Hirslanden operates 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operates 52 hospitals, five sub-acute hospitals and 12 day case clinics with more than 8 500 inpatient beds; and Mediclinic Middle East operates seven hospitals, two day case clinics and 21 outpatient clinics with more than 900 inpatient beds in the United Arab Emirates. The Company's primary listing is on the London Stock Exchange ("LSE") in the United Kingdom, with secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE. For further information, please contact: Company Secretary, Link Company Matters Limited Jayne Meacham / Caroline Emmet +44 (0)20 7954 9569 Investor Relations, Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com +44 (0)20 3786 8181 Media queries FTI Consulting Brett Pollard/Debbie Scott - UK +44 (0)20 3727 1000 Sherryn Schooling - South Africa +27 (0)21 487 9000 Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank JSE Ltd sponsor: Rand Merchant Bank (A division of FirstRand Bank Ltd) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 12/07/2019 01:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.